Opthea Limited Sponsored ADR (OPT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Opthea Limited, a biopharmaceutical company focused on innovative treatments for retinal diseases, will engage with investors at the Citi 2024 Global Healthcare Conference. CEO Fred Guerard will lead discussions on Opthea’s advancements, highlighting their Phase 3 trials aimed at enhancing treatment efficacy for conditions like wet age-related macular degeneration.
For further insights into OPT stock, check out TipRanks’ Stock Analysis page.
